Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1
Cancer stem cells in neuroblastoma therapy resistance
Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement
Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies
Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs
Exosomal lncRNAs: the newest promising liquid biopsy
In search of effective therapies to overcome resistance to Temozolomide in brain tumours
Kinase inhibitors: look beyond the label on the bottle
Liquid biopsies in myeloid malignancies
Liquid biopsy in metastatic breast cancer
Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics
MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution
Network rewiring, adaptive resistance and combating strategies in breast cancer
Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence
RET in breast cancer: pathogenic implications and mechanisms of drug resistance
Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts
The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia
The role of exosomal long non-coding RNAs in cancer drug resistance
Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways
Components of the human-specific, p53-mediated “kill switch” tumor suppression mechanism are usurped by human tumors, creating the possibility of therapeutic exploitation
Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer